Over the past month, I've encountered the same set of questions in multiple forums, all centering on Anthropic's Claude Mythos—an AI model that claims to find and weaponize vulnerabilities at an unprecedented scale. The issue? Almost nobody can actually use it, test it, or verify its claims.
These questions come from teams trying to make real decisions: Should you budget for AI-assisted scanning? How do you validate findings? What happens when your auditor asks about your vulnerability detection process? Here's what you need to know.
Is AI Scanning Better Than Current Tools?
The numbers are striking. Mythos took a set of Firefox vulnerabilities and weaponized them into 181 usable attacks. Security contractors reviewing the AI's severity ratings agreed 89% of the time across 198 assessments.
However, here's what matters for your program: we don't know the false positive rate. We don't know how it performs against the vulnerabilities in your stack. We don't know if that 89% agreement rate holds up across different codebases, languages, or vulnerability types.
For context, your current SAST tools probably have a false positive rate between 30-70%, depending on tuning. If Mythos has a 10% false positive rate, that's transformative. If it's 40%, it's just expensive noise with a better UI.
You can't make a build-or-buy decision without this data. If a vendor can't tell you their false positive rate in a production environment similar to yours, you're buying a promise, not a tool.
Evaluating AI Scanners for Compliance
You can't evaluate Mythos for SOC 2 Type II or PCI DSS v4.0.1 scope effectively.
When documenting your vulnerability management program for SOC 2 Type II (CC7.1) or PCI DSS v4.0.1 (Requirement 6.3.2), your auditor will ask how you identify vulnerabilities and validate your tools' effectiveness. "We're using an AI model that 50 organizations have access to, and we can't verify its accuracy" is not a control description that survives scrutiny.
This matters more for your risk register than your tool budget. If you're relying on AI-assisted scanning as a primary control, you need to be able to test it, red-team it, and demonstrate its effectiveness. Restricted access means you can't do any of that.
For now, treat any AI vulnerability scanner—including Mythos if you somehow get access—as a supplementary control. Your primary detection still needs to be tools you can validate independently.
Managing False Positives
The 89% severity agreement statistic is tricky. Agreement on severity is not the same as agreement on exploitability. A vulnerability can be correctly rated as "high severity" but still not be exploitable in your specific configuration.
If Mythos identifies 181 potential attack vectors in a component you depend on, your team has to triage all 181. Even if only 20 are false positives, that's 20 engineer-hours wasted. At scale, across your entire application portfolio, false positives become a resource allocation problem.
The OWASP ASVS v4.0.3 framework is helpful here. Section 14.2 covers vulnerability management and specifically calls out the need to "verify that the vulnerability management process includes a mechanism to eliminate false positives." You can't eliminate what you can't measure.
Until we have public benchmarks—ideally against something like the OWASP Benchmark Project or a shared CVE dataset—you should assume any AI scanner has a false positive rate similar to traditional SAST tools. Plan your triage capacity accordingly.
Who Should Control Powerful Tools?
This is the question keeping compliance teams up at night.
When a private company controls a tool that can identify vulnerabilities across critical infrastructure, they're making decisions that affect your risk posture without your input. You can't assess the tool's limitations. You can't test it against your threat model. You can't verify that it's not missing entire classes of vulnerabilities.
For regulated industries, this creates a compliance gap. The NIST Cybersecurity Framework v2.0 (ID.RA-1) requires you to identify and document vulnerabilities in your assets. If your vulnerability identification depends on a tool you can't audit, you're building your risk assessment on a black box.
The parallel here is the debate around responsible disclosure. The security community settled on coordinated disclosure because keeping vulnerabilities secret—even with good intentions—ultimately makes systems less secure. The same principle applies to security tools. Restricted access to Mythos means the community can't pressure-test it, can't identify its blind spots, and can't develop compensating controls for its limitations.
Planning for AI-Assisted Detection
Yes, plan for AI-assisted vulnerability detection, but not as a replacement for your current program.
Start with a pilot scope: one application, one team, three months. Run AI-assisted scanning in parallel with your existing tools. Track:
- Unique vulnerabilities found by AI that your current tools missed
- False positives that consumed engineering time
- Time to triage and validate findings
- Cost per finding compared to your current cost per finding
Document this as part of your continuous improvement process under ISO 27001 (Clause 10.1). Your auditor will appreciate the methodical approach, and you'll have data to justify (or reject) expanded use.
Critically: don't wait for Mythos access. Other AI-assisted scanning tools exist today with fewer restrictions. Test those first. Build your evaluation framework now so you're ready when broader access becomes available.
Questions to Ask AI-Powered Vendors
Ask for their false positive rate in production environments. Ask for their detection rate against OWASP Top 10 2021 categories. Ask how they handle novel vulnerability classes that weren't in their training data.
Then ask the harder question: "Can we test this ourselves before we buy?" If the answer is no, you're not evaluating a tool—you're taking a vendor's word for it.
Next Steps
The cybersecurity community needs to push for transparency in AI security tools the same way we pushed for transparency in vulnerability disclosure. That means public benchmarks, independent testing, and open discussion of limitations.
For your team right now: document your current vulnerability detection capabilities, establish your baseline metrics, and start small pilots with whatever AI-assisted tools you can actually test. When Mythos or similar models become more widely available, you'll have the framework to evaluate them properly.
And if you're in one of those 50 Project Glasswing organizations? Publish your findings. The community needs the data.
